Therapeutic Advances in Pulmonary and Critical Care Medicine
Scope & Guideline
Unlocking new horizons in pulmonary medicine.
Introduction
Aims and Scopes
- Pulmonary Diseases and Conditions:
The journal focuses on a wide range of pulmonary diseases, including but not limited to tuberculosis, pneumonia, and lung cancer. It aims to publish studies that enhance the understanding of these conditions, their pathophysiology, and innovative treatment options. - Critical Care Medicine:
This area encompasses research related to the management and treatment of critically ill patients, highlighting advancements in monitoring, therapeutic interventions, and outcomes in intensive care settings. - Therapeutic Innovations:
The journal emphasizes innovative therapeutic approaches, including pharmacological treatments, surgical interventions, and novel technologies that improve patient outcomes in pulmonary and critical care. - Clinical Case Reports and Reviews:
It encourages the submission of detailed clinical case reports and comprehensive reviews that provide insights into unique patient scenarios or summarize existing literature on specific topics in pulmonary and critical care.
Trending and Emerging
- Complications of Pulmonary Diseases:
Recent publications have increasingly focused on complex complications arising from pulmonary diseases, such as tension pneumothorax and bronchopleural fistulas, indicating a growing interest in managing severe manifestations of respiratory conditions. - Case Reports of Rare Conditions:
There is a trend towards documenting rare cases, such as spontaneous pneumomediastinum in adolescents, showcasing unique clinical presentations and enhancing the medical community's understanding of less common pulmonary events. - Innovative Diagnostic Techniques:
The review of thromboelastography (TEG) suggests a rising interest in advanced diagnostic methods that improve the assessment and management of critical care patients, reflecting the journal's commitment to integrating new technologies in clinical practice.
Declining or Waning
- Traditional Respiratory Therapies:
There has been a noticeable decrease in publications focusing on traditional respiratory therapies, such as older forms of mechanical ventilation and basic inhalation therapies, as newer and more effective modalities gain traction. - Epidemiological Studies:
Research centered on the epidemiology of common pulmonary diseases has become less frequent, possibly due to a shift towards more targeted and innovative therapeutic research rather than broad population studies.
Similar Journals
Tuberkuloz ve Toraks-Tuberculosis and Thorax
Exploring critical insights in thoracic medicine.Tuberkuloz ve Toraks (Tuberculosis and Thorax) is a distinguished journal published by the TURKISH ASSOCIATION OF TUBERCULOSIS AND THORAX located in Turkey. Serving as a pivotal platform for researchers and practitioners in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, this journal has been disseminating vital research since 2003 and is committed to advancing knowledge and clinical practices related to tuberculosis and thoracic diseases. Although currently not an Open Access publication, its relevance is underscored by its rankings within Scopus, including a Q3 category in Critical Care and Intensive Care Medicine and a Q4 in Pulmonary and Respiratory Medicine, reflecting its significant contributions to the academic community. With a mission to foster the exchange of innovative ideas and encourage rigorous scholarly discourse, Tuberkuloz ve Toraks plays an essential role in addressing pressing health challenges associated with respiratory ailments and remains an invaluable resource for researchers, health professionals, and students dedicated to improving outcomes in thoracic health.
DM DISEASE-A-MONTH
Uncovering Critical Health Insights Monthly.DM DISEASE-A-MONTH is a leading monthly journal published by MOSBY-ELSEVIER, dedicated to disseminating pivotal research and insights across the spectrum of general medicine. With a history spanning from 1954 to 2024, this journal has established itself as a key resource within the field, reflecting its commitment to advancing medical knowledge and practice. As evidenced by its impressive Scopus ranking—currently at #79 out of 636 in General Medicine and falling within the 87th percentile—this journal occupies a prominent position in the medical literature landscape. Although not an open-access publication, DM DISEASE-A-MONTH continues to serve a diverse audience of researchers, healthcare professionals, and medical students, providing valuable updates on recent advances in medicine and enabling its readers to stay informed about emerging trends and critical health issues. Its current Q2 category ranking in the 2023 Medical (miscellaneous) field further underscores its relevance and impact, making it an essential addition to the library of any medical practitioner or researcher.
Indian Journal of Respiratory Care
Empowering Knowledge in Respiratory CareWelcome to the Indian Journal of Respiratory Care, a premier platform dedicated to advancing research and clinical practices in the field of respiratory health. Published by JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD, this journal has established itself as a crucial resource for researchers, healthcare professionals, and educators since embracing an Open Access model in 2012, ensuring maximum visibility and accessibility of vital research findings. The journal aims to disseminate high-quality articles encompassing a wide range of topics, including but not limited to, respiratory diseases, pulmonary care, and innovative treatment approaches. With its commitment to fostering collaboration and knowledge exchange, the Indian Journal of Respiratory Care is poised to make a significant impact in the ever-evolving landscape of respiratory medicine. As the field continues to grow, this journal serves as an essential touchpoint for those invested in enhancing patient care and outcomes.
CURRENT OPINION IN PULMONARY MEDICINE
Fostering Dialogue in Respiratory AdvancementsCurrent Opinion in Pulmonary Medicine, published by Lippincott Williams & Wilkins, is a vital resource for professionals in the field of pulmonary and respiratory medicine. With a robust ISSN of 1070-5287 and an E-ISSN of 1531-6971, this journal has been converging insightful research and expert opinions since 1995. It currently holds a respectable Q2 category ranking in the 2023 Scopus rankings for pulmonary and respiratory medicine, placing it within the 74th percentile of its field. The journal provides an excellent platform for clinicians, researchers, and students to keep abreast of the latest developments, trends, and therapeutic advances, ensuring that it remains an essential component of ongoing education and scholarship in respiratory health. While not open access, the journal offers various subscription options to facilitate access to cutting-edge pulmonary research. Located in Philadelphia, Pennsylvania, Current Opinion in Pulmonary Medicine continues to shape the future of respiratory medicine through its commitment to high-quality content and academic excellence.
Annals of the American Thoracic Society
Shaping the future of respiratory medicine with cutting-edge insights.Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.
Respiratory Medicine Case Reports
Championing open access to vital respiratory research.Respiratory Medicine Case Reports is a dynamic open-access journal published by Elsevier, dedicated to the timely dissemination of case reports in the field of pulmonary and respiratory medicine. With an ISSN of 2213-0071 and a focus on innovative clinical practices, the journal serves as a crucial resource for researchers, clinicians, and students alike, contributing significantly to the advancement of knowledge in respiratory health. Since its inception in 2012, it has built a solid reputation within the academic community, currently ranking in the Q3 category in the field. The journal also holds a position within the 33rd percentile of its Scopus ranking, reflecting the quality and relevance of its published content. Situated in the United Kingdom and accessible globally, it provides a platform for the open exchange of ideas, encouraging submissions that enhance the understanding of complex cases and foster collaboration within the scientific community. Explore this resource to stay at the forefront of advancements in respiratory medicine and to contribute to the growing body of literature in this vital area.
LUNG
Innovating the future of pulmonary medicine with every publication.LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.
Canadian Journal of Respiratory Critical Care and Sleep Medicine
Advancing knowledge in respiratory and critical care.Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.
Advances in Respiratory Medicine
Fostering collaboration for a healthier tomorrow.Advances in Respiratory Medicine is a distinguished open-access journal published by MDPI, focusing on the latest research and developments in the field of pulmonary and respiratory medicine. Launched in 2015 and operating out of Switzerland, this journal aims to advance scientific discourse and knowledge by providing a platform for researchers, clinicians, and health professionals. With an impressive ISSN of 2451-4934 and an E-ISSN of 2543-6031, it has made its mark in the academic community, reflected by its impact factor and recognition in the Q3 category for Pulmonary and Respiratory Medicine as of 2023. The journal enjoys a ranking of #95 out of 155 in Scopus within its category, providing authors with visibility and the potential for impactful dissemination of their research. Open access since 2022, it ensures that findings are readily available to all, fostering collaboration and innovation across disciplines. With a commitment to quality and rigor, Advances in Respiratory Medicine invites contributions that push the boundaries of existing knowledge, making it an invaluable resource for anyone dedicated to enhancing respiratory health.
Respirology Case Reports
Exploring complex respiratory conditions.Respirology Case Reports is a distinguished peer-reviewed journal published by WILEY, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2013, this Open Access journal has provided a platform for the publication of high-quality case reports that enhance our understanding of various respiratory conditions, fostering collaboration and knowledge dissemination among healthcare professionals, researchers, and students alike. With an impact factor that reflects its growing influence, Respirology Case Reports aims to illuminate rare and complex cases, thus contributing vital insights that enhance clinical practice. Located in the United Kingdom, this journal serves as an essential resource for advancing research and improving patient outcomes in respiratory health. Currently ranked in the Q3 quartile for Pulmonary and Respiratory Medicine, it showcases case studies that not only enrich academic discourse but also promote the application of evidence-based practices in real-world settings.